In Silico Drug Design: Repurposing Techniques and Methodologies
Editat de Kunal Royen Limba Engleză Paperback – 15 feb 2019
- Discusses the theoretical background and methodologies of useful techniques of cheminformatics and bioinformatics that can be applied for drug repurposing
- Offers case studies relating to the in silico modeling of FDA-approved drugs for the discovery of antifungal, anticancer, antiplatelet agents, and for drug therapies against diseases
- Covers tools and databases that can be utilized to facilitate in silico methods for drug repurposing
Preț: 851.19 lei
Preț vechi: 1113.29 lei
-24% Nou
Puncte Express: 1277
Preț estimativ în valută:
162.91€ • 169.42$ • 136.32£
162.91€ • 169.42$ • 136.32£
Carte tipărită la comandă
Livrare economică 07-21 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128161258
ISBN-10: 0128161256
Pagini: 886
Dimensiuni: 191 x 235 mm
Greutate: 1.49 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0128161256
Pagini: 886
Dimensiuni: 191 x 235 mm
Greutate: 1.49 kg
Editura: ELSEVIER SCIENCE
Public țintă
Research Scientists, Pharmaceutical R&D, Pharmaceutical Regulatory Authorities (such as FDA, OECD), postgraduates and postdoctoral researchers in the fields of Pharmaceutical Sciences,Pharmacology, Medicinal Chemistry, Bioinformatics,CheminformaticsCuprins
Section 1. Introduction
1. Drug Repositioning: New Opportunities for Older Drugs
2. Computational Drug Design Methods – Current and Future Perspectives
Section 2. Theoretical Background and Methodologies
3. In Silico Drug Design Methods for Drug Repurposing
4. Computational Drug Repurposing for Neurodegenerative Diseases
5. Repurposed molecules: A New Hope in Tackling Neglected Infectious Diseases
6. Molecular Docking: A Structure-Based Approach for Drug Repurposing
7. Data Science Driven Drug Repurposing for Metabolic Disorders
8. Data-driven Systems Level Approaches for Drug Repurposing: Combating Drug Resistance in Priority Pathogens
9. In Silico Repurposing of Cell Cycle Modulators for Cancer Treatment
10. Proteochemometric Modeling for Drug Repositioning
11. Drug Repurposing from Transcriptome Data: Methods and Applications
12. Omics-driven Knowledge Based Discovery of Anthelmintic Targets and Drugs
13. Analysis of Chemical Spaces: Implications for Drug Repurposing
Section 3. Examples and Case Studies
14. Drug Repurposing in Search of Anti-Infectives: Need of the Hour in the Multi-Drug Resistance Era!
15. Application of In Silico Drug Repurposing in Infectious Diseases
16. In Silico Modeling of FDA-approved Drugs for Discovery of Anti-candida Agents: A Drug Repurposing Approach
17. In silico Modeling of FDA-approved Drugs for Discovery of Anticancer Agents: A Drug Repurposing Approach
18. Tackling Lung Cancer Drug Resistance using Integrated Drug Repurposing Strategy
19. In Silico Modeling of FDA-approved Drugs for Discovery of Anti-cancer Agents: A Drug Repurposing Approach
20. Drug Repurposing by Connectivity Mapping and Structural Modeling
21. In Silico Modeling of FDA-approved Drugs for Discovery of Therapies Against Neglected Diseases: A Drug Repurposing Approach
22. Ascorbic Acid is a Potential Inhibitor of Collagenases – In Silico and In Vitro Biological Studies
23. Bioinformatic Approaches for Repurposing and Repositioning Antibiotics, Antiprotozoals and
Antivirals
Section 4. Tools and databases
24. In Silico Databases and Tools for Drug Repurposing
25. An Overview of Computational Methods, Tools, Servers and Databases for Drug Repurposing
26. In silico Drug Repurposing for MDR Bacteria: Opportunities and Challenges
27. Drug Repositioning Strategies to Explore New Candidates Treating Prostate Cancer
28. PDID: Database of Experimental and Putative Drug Targets in Human Proteome
1. Drug Repositioning: New Opportunities for Older Drugs
2. Computational Drug Design Methods – Current and Future Perspectives
Section 2. Theoretical Background and Methodologies
3. In Silico Drug Design Methods for Drug Repurposing
4. Computational Drug Repurposing for Neurodegenerative Diseases
5. Repurposed molecules: A New Hope in Tackling Neglected Infectious Diseases
6. Molecular Docking: A Structure-Based Approach for Drug Repurposing
7. Data Science Driven Drug Repurposing for Metabolic Disorders
8. Data-driven Systems Level Approaches for Drug Repurposing: Combating Drug Resistance in Priority Pathogens
9. In Silico Repurposing of Cell Cycle Modulators for Cancer Treatment
10. Proteochemometric Modeling for Drug Repositioning
11. Drug Repurposing from Transcriptome Data: Methods and Applications
12. Omics-driven Knowledge Based Discovery of Anthelmintic Targets and Drugs
13. Analysis of Chemical Spaces: Implications for Drug Repurposing
Section 3. Examples and Case Studies
14. Drug Repurposing in Search of Anti-Infectives: Need of the Hour in the Multi-Drug Resistance Era!
15. Application of In Silico Drug Repurposing in Infectious Diseases
16. In Silico Modeling of FDA-approved Drugs for Discovery of Anti-candida Agents: A Drug Repurposing Approach
17. In silico Modeling of FDA-approved Drugs for Discovery of Anticancer Agents: A Drug Repurposing Approach
18. Tackling Lung Cancer Drug Resistance using Integrated Drug Repurposing Strategy
19. In Silico Modeling of FDA-approved Drugs for Discovery of Anti-cancer Agents: A Drug Repurposing Approach
20. Drug Repurposing by Connectivity Mapping and Structural Modeling
21. In Silico Modeling of FDA-approved Drugs for Discovery of Therapies Against Neglected Diseases: A Drug Repurposing Approach
22. Ascorbic Acid is a Potential Inhibitor of Collagenases – In Silico and In Vitro Biological Studies
23. Bioinformatic Approaches for Repurposing and Repositioning Antibiotics, Antiprotozoals and
Antivirals
Section 4. Tools and databases
24. In Silico Databases and Tools for Drug Repurposing
25. An Overview of Computational Methods, Tools, Servers and Databases for Drug Repurposing
26. In silico Drug Repurposing for MDR Bacteria: Opportunities and Challenges
27. Drug Repositioning Strategies to Explore New Candidates Treating Prostate Cancer
28. PDID: Database of Experimental and Putative Drug Targets in Human Proteome